> top > docs > PMC:7205724 > spans > 242-465 > annotations

PMC:7205724 / 242-465 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
3 10-17 Species denotes patient Tax:9606
5 89-97 Disease denotes COVID-19 MESH:C000657245
7 172-180 Disease denotes COVID-19 MESH:C000657245
10 185-188 Gene denotes IL6 Gene:3569

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T2 89-97 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T3 172-180 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T4 42-57 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858
T5 152-167 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858

LitCovid-sample-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T3 42-57 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858
T4 152-167 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858

LitCovid-sample-PD-NCBITaxon

Id Subject Object Predicate Lexical cue ncbi_taxonomy_id
T2 89-97 Species denotes COVID-19 NCBItxid:2697049
T3 172-180 Species denotes COVID-19 NCBItxid:2697049

LitCovid-sample-sentences

Id Subject Object Predicate Lexical cue
T6 28-98 Sentence denotes • The use of corticosteroids might accelerate recovery from COVID-19.
T7 99-181 Sentence denotes • No controlled clinical trials exist on the use of corticosteroids for COVID-19.

LitCovid-sample-Pubtator

Id Subject Object Predicate Lexical cue pubann:denotes
3 10-17 Species denotes patient Tax:9606
5 89-97 Disease denotes COVID-19 MESH:C000657245
7 172-180 Disease denotes COVID-19 MESH:C000657245
10 185-188 Gene denotes IL6 Gene:3569

LitCovid-sample-UniProt

Id Subject Object Predicate Lexical cue uniprot_id
T1 185-188 Protein denotes IL6 https://www.uniprot.org/uniprot/Q9XT80|https://www.uniprot.org/uniprot/Q9UCU4|https://www.uniprot.org/uniprot/Q9UCU3|https://www.uniprot.org/uniprot/Q9UCU2|https://www.uniprot.org/uniprot/Q9MZR1|https://www.uniprot.org/uniprot/Q9MYZ7|https://www.uniprot.org/uniprot/Q95KN6|https://www.uniprot.org/uniprot/Q95181|https://www.uniprot.org/uniprot/Q90YI0|https://www.uniprot.org/uniprot/Q8MKH0|https://www.uniprot.org/uniprot/Q8BN26|https://www.uniprot.org/uniprot/Q865X6|https://www.uniprot.org/uniprot/Q865W7|https://www.uniprot.org/uniprot/Q6V919|https://www.uniprot.org/uniprot/Q6L6X6|https://www.uniprot.org/uniprot/Q5I6E3|https://www.uniprot.org/uniprot/Q3UCQ0|https://www.uniprot.org/uniprot/Q2MH06|https://www.uniprot.org/uniprot/Q28819|https://www.uniprot.org/uniprot/Q28747|https://www.uniprot.org/uniprot/Q28319|https://www.uniprot.org/uniprot/Q25BC2|https://www.uniprot.org/uniprot/Q0PW36|https://www.uniprot.org/uniprot/Q0GGL7|https://www.uniprot.org/uniprot/Q08DT2|https://www.uniprot.org/uniprot/P79341|https://www.uniprot.org/uniprot/P51494|https://www.uniprot.org/uniprot/P46650|https://www.uniprot.org/uniprot/P41693|https://www.uniprot.org/uniprot/P41683|https://www.uniprot.org/uniprot/P41323|https://www.uniprot.org/uniprot/P29455|https://www.uniprot.org/uniprot/P26893|https://www.uniprot.org/uniprot/P26892|https://www.uniprot.org/uniprot/P20607|https://www.uniprot.org/uniprot/P08505|https://www.uniprot.org/uniprot/P05231|https://www.uniprot.org/uniprot/O46568|https://www.uniprot.org/uniprot/O35736|https://www.uniprot.org/uniprot/O19007|https://www.uniprot.org/uniprot/B6CKP4|https://www.uniprot.org/uniprot/A9QWQ9|https://www.uniprot.org/uniprot/A3FBE9|https://www.uniprot.org/uniprot/A0S0B0

LitCovid-sample-Enju

Id Subject Object Predicate Lexical cue
T34 2-9 VB denotes improve
T35 10-17 NN denotes patient
T36 18-26 NNS denotes outcomes
T37 28-29 PDT denotes •
T38 31-34 DT denotes The
T39 35-38 NN denotes use
T40 39-41 IN denotes of
T41 42-57 NNS denotes corticosteroids
T42 58-63 MD denotes might
T43 64-74 VB denotes accelerate
T44 75-83 NN denotes recovery
T45 84-88 IN denotes from
T46 89-97 NN denotes COVID-19
T47 99-100 PDT denotes •
T48 102-104 DT denotes No
T49 105-115 VBN denotes controlled
T50 116-124 JJ denotes clinical
T51 125-131 NNS denotes trials
T52 132-137 VBP denotes exist
T53 138-140 IN denotes on
T54 141-144 DT denotes the
T55 145-148 NN denotes use
T56 149-151 IN denotes of
T57 152-167 NNS denotes corticosteroids
T58 168-171 IN denotes for
T59 172-180 NN denotes COVID-19
T60 182-183 LS denotes •
T61 185-188 NN denotes IL6
T62 189-199 VBZ denotes correlates
T63 200-204 IN denotes with
T64 205-213 NN denotes severity
T65 213-214 -COMMA- denotes ,
R31 T36 T34 arg2Of outcomes,improve
R32 T36 T35 arg1Of outcomes,patient
R33 T39 T37 arg1Of use,•
R34 T39 T38 arg1Of use,The
R35 T39 T40 arg1Of use,of
R36 T41 T40 arg2Of corticosteroids,of
R37 T39 T42 arg1Of use,might
R38 T43 T42 arg2Of accelerate,might
R39 T39 T43 arg1Of use,accelerate
R40 T44 T43 arg2Of recovery,accelerate
R41 T44 T45 arg1Of recovery,from
R42 T46 T45 arg2Of COVID-19,from
R43 T51 T47 arg1Of trials,•
R44 T51 T48 arg1Of trials,No
R45 T51 T49 arg2Of trials,controlled
R46 T51 T50 arg1Of trials,clinical
R47 T51 T52 arg1Of trials,exist
R48 T52 T53 arg1Of exist,on
R49 T55 T53 arg2Of use,on
R50 T55 T54 arg1Of use,the
R51 T55 T56 arg1Of use,of
R52 T57 T56 arg2Of corticosteroids,of
R53 T55 T58 arg1Of use,for
R54 T59 T58 arg2Of COVID-19,for
R55 T62 T60 arg1Of correlates,•
R56 T61 T62 arg1Of IL6,correlates
R57 T62 T63 arg1Of correlates,with
R59 T64 T65 arg1Of severity,","

LitCovid-sample-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T2 89-97 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T3 172-180 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T6 28-98 Sentence denotes • The use of corticosteroids might accelerate recovery from COVID-19.
T7 99-181 Sentence denotes • No controlled clinical trials exist on the use of corticosteroids for COVID-19.